FTC Challenges Grifols/Talecris Merger as Anticompetitive
Settlement Requires Grifols to Divest Assets in the Plasma-Derived Drug Industry The Federal Trade Commission will require Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing …